Lipofilling Versus Conservative Treatment in Fingertips Injuries Sequelae
Launched by UNIVERSITY HOSPITAL, BREST · Aug 30, 2019
Trial Information
Current as of July 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called lipofilling, which involves reinjecting fat from the patient's own body, to see if it can help people who have ongoing discomfort in their fingertip area after a finger injury. Specifically, the researchers want to find out if this treatment can improve the quality of life for patients who have had a part of their finger amputated and are experiencing pain or sensitivity in that area for at least six months, but less than two years.
To participate in this trial, you need to be between 18 and 75 years old and have had a single finger injury that was treated either with a specific healing method or with a skin flap. You should also be experiencing noticeable discomfort, measured by a pain scale, and have no allergies to the anesthetics used in the procedure. If you qualify and decide to join, you can expect to receive the lipofilling treatment, and the research team will closely monitor your progress. It's important to note that this study is currently looking for participants, so if you or someone you know fits the criteria and is interested, it could be a valuable opportunity for relief.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Major patient (18 years old) and ≤ 75 years old
- • Patient with unidigital trauma downstream of distal interphalangeal joint
- • Treated by directed healing OR covered by a flap
- • Presenting troublesome pulpal dysesthesia evolving for more than 6 months AND less than 24 months
- • The discomfort must be objectified by a DN4 score greater than or equal to 4/10 (neuropathic pain)
- • Patient does not have any allergy to the substances used, in particular anesthetic: xylocaine, adrenaline
- Exclusion Criteria:
- • Patient with cutaneous sepsis, or amputation upstream of distal interphalangeal, or reimplantation, or dysesthesia that has been in progress for more than 24 months, or multi-digital traumatism
- • Refusal of the patient to integrate the protocol Or incapacity to consent
- • Pregnant or breastfeeding woman
- • Tumor history of the amputated finger
About University Hospital, Brest
The University Hospital of Brest is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. With a strong emphasis on interdisciplinary collaboration, the hospital serves as a hub for cutting-edge clinical trials aimed at improving treatment outcomes across various medical specialties. Leveraging its robust academic affiliations and state-of-the-art facilities, the University Hospital of Brest is committed to fostering scientific discovery and enhancing the quality of life for patients through evidence-based practices and pioneering research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brest, , France
Quimper, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials